News

November 17, 2008	Study suggests Siemens non-invasive blood test may have a role in monitoring breast cancer patients' response to Herceptin
January 3, 2007	Acquisition of Bayer's Diagnostic Division Finalized
June 5, 2006	Serum HER-2/neu Change Predicts Clinical Outcome to Trastuzumab-Based Therapy
May 19, 2002	NEW STUDY SHOWS VALUE OF MONITORING WITH HER-2/NEU BLOOD TEST; Findings Define HER-2/neu Target in Metastatic Breast Cancer
December 5, 2001	American Medical Association Approves New CPT Code for SERUM HER-2/neu ONCOPROTEIN Test
December 6, 2000	FDA Clears Bayer Serum HER-2/neu Oncoprotein Test For Breast Cancer Monitoring